Michael V. Novinski, Chief Executive Officer
An experienced leader in the pharmaceutical and biotechnology fields with a special focus on reproductive health, Michael V. Novinski has more than 35 years of life sciences experience. He held the position of president of Organon BioSciences USA, a biopharmaceutical company focused on female reproductive health acquired by Schering-Plough Corporation, and also served as executive VP, Operations and Marketing for NV Organon while residing in Europe. He has commercialized more than 15 products through FDA approval and an additional 10 on a worldwide basis.
Michael served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA) for four years, and is the author of ALL for one and ONE for all, which was released by Tate Publishing in May 2013. He has several patents for both innovative pharmaceutical formulations and packaging, and has been recognized in Business Week, Drug Delivery Technology, and BioWorld, among other news outlets.
Alexander J. Travis, VMD, PhD, Chief Scientific Officer
An associate professor at Cornell University, Dr. Alex Travis is a world leader in the research of capacitation, and head of a laboratory focused on the investigation of the biology of male reproductive cells. His research was the first to link GM1 localization with capacitation status, thereby showing it to be a biomarker for sperm fertilizing ability, and laying the groundwork for the laboratory-developed test being developed by Androvia. Alex has also conducted research in the areas of reproductive health that may one day be used to aid reproduction in humans and prevent extinction in certain animal species.
Alex graduated from Princeton University magna cum laude. He received a Diploma in Reproductive Science from Monash University under a Rotary Graduate Fellowship. He received both his VMD and PhD at the University of Pennsylvania, from which he graduated summa cum laude with the Leonard Pearson Prize, the veterinary school’s highest honor. Among other awards, he was the first veterinarian to ever receive a Pioneer Award from the National Institutes of Health and he has received the State University of New York Chancellor’s Award for Excellence in Scholarship and Creative Activities.
Michael Weiser, MD, PhD
Dr. Weiser is a founder of Actin Biomed, a New York-based health care investment firm that supports the development of treatments for unmet medical needs and is among the financers of Androvia.
Jason Stein, MD
Dr. Stein is a founder of Actin Biomed, a New York-based health care investment firm that supports the development of treatments for unmet medical needs and is among the financers of Androvia.
Gianpiero D. Palermo, MD, PhD
Professor of reproductive medicine at Weill Cornell Medical College of Cornell University, Dr. Palermo developed the revolutionary fertility procedure in which a single sperm is directly injected into a mature egg, intracytoplasmic sperm injection (ICSI). Dr. Palermo has been involved in research related to capacitation, the process that is the basis of Cap-Score and the Cap-Score Sperm Function Test, Androvia’s laboratory-based assay under development.
Jay S. Schinfeld, MD, FACOG
Dr. Schinfeld is the Founder of Abington Reproductive Medicine and also the founding Director of the Division of Reproductive Endocrinology and Infertility at Abington Memorial Hospital in Pennsylvania. Dr. Schinfeld has more than 40 years of experience in the field of infertility and is highly revered as Clinical Professor at Jefferson Medical College and Adjunct Professor OB/GYN at Temple University School of Medicine. Among Dr. Schinfeld’s many areas of interest and expertise are preimplantation genetics, in vitro fertilization and intracytoplasmic sperm injection.
Eric K. Seaman, MD
Founder and Director of the Center for Vasectomy, Vasectomy Reversal and Male Infertility of New Jersey, Dr. Seaman has specialized in male fertility for more than 18 years. Dr. Seaman is a board certified urologist, passionately focused on Male Reproductive Medicine and specializes in microsurgical techniques including vasectomy reversals and surgical sperm retrievals. Dr. Seaman has been recognized as one of New Jersey’s “Top Doctors” for the past 4 years.
Fady I. Sharara, MD, FACOG
Dr. Sharara is the Founder and Medical Director of the Virginia Center for Reproductive Medicine. Dr. Sharara has published more than 80 scientific papers addressing issues of infertility and currently serves as a reviewer for two leading scientific journals in the field, Fertility and Sterility and Human Reproduction. In 2004, Dr. Sharara was recognized as International Scientist of the Year. Dr. Sharara has also served as a member of the Society of Assisted Reproductive Technology (SART) Practice Committee since 2007, a six member committee responsible for updating protocols for the latest Assisted Reproductive Technologies. Dr. Sharara currently holds the position of Clinical Professor OB/GYN at the George Washington University in Washington, D.C.